de Gast, G C
1048  Ergebnisse:
Personensuche X
?
1

Lack of anti-tumour reactivity despite enhanced numbers of ..:

Vyth-Dreese, F A ; Sein, J ; Van De Kasteele, W...
Clinical and Experimental Immunology.  162 (2010)  3 - p. 447-459 , 2010
 
?
3

Evidence for transfer of cellular and humoral immunity to c..:

BOLAND, G J ; VLIEGER, A M ; VERVERS, C.
Clinical and Experimental Immunology.  88 (2008)  3 - p. 506-511 , 2008
 
?
4

Factors influencing the occurrence of active cytomegaloviru..:

BOLAND, G J ; HENE, R J ; VERVERS, C..
Clinical and Experimental Immunology.  94 (2008)  2 - p. 306-312 , 2008
 
?
5

Prolonged low dose IL-2 and thalidomide in progressive meta..:

Kerst, J. M. ; Bex, A. ; Mallo, H....
Cancer Immunology, Immunotherapy.  54 (2005)  9 - p. 926-931 , 2005
 
?
 
?
9

Targeted toxins:

den Brok, M.W.J. ; de Gast, G.C. ; Schellens, J.H.M..
Journal of Oncology Pharmacy Practice.  5 (1999)  4 - p. 149-165 , 1999
 
?
 
?
11

Targeted toxins:

Brok, M W J den ; de Gast, G C ; Schellens, J H M.
Journal of Oncology Pharmacy Practice.  5 (1999)  4 - p. 149-165 , 1999
 
?
12

Toward preclinical studies with anti-CD86 immunotoxin:

Otten, H.G ; Ossevoort, M ; Vooijs, W.C...
Transplantation Proceedings.  31 (1999)  1-2 - p. 1236 , 1999
 
?
 
1-15